FDCPharmaceuticals

FDC LtdCash Flow Statement

321.10
-2.67%

FDC Ltd Cash Flow Statement (Annual)

Metric20252024202320222021
Free Cash Flow220.85 Cr127.37 Cr41.82 Cr29.11 Cr
Repurchase Of Capital Stock0.00-155.00 Cr-137.75 Cr0.00
Repayment Of Debt-0.03 Cr-0.08 Cr-0.10 Cr-0.14 Cr
Capital Expenditure-96.72 Cr-93.39 Cr-113.09 Cr-132.54 Cr
End Cash Position51.47 Cr25.42 Cr23.89 Cr37.73 Cr
Beginning Cash Position25.42 Cr23.89 Cr37.73 Cr30.43 Cr
Effect Of Exchange Rate Changes0.12 Cr67000.000.06 Cr0.05 Cr
Changes In Cash25.94 Cr1.53 Cr-13.90 Cr7.25 Cr
Financing Cash Flow-92.12 Cr-202.16 Cr-179.95 Cr-9.84 Cr
Interest Paid Cff-2.80 Cr-2.68 Cr-0.52 Cr-0.59 Cr
Cash Dividends Paid-81.13 Cr-0.15 Cr-0.18 Cr
Net Common Stock Issuance0.00-155.00 Cr-137.75 Cr0.00
Common Stock Payments0.00-155.00 Cr-137.75 Cr0.00
Net Issuance Payments Of Debt-0.03 Cr-0.08 Cr-0.10 Cr-0.14 Cr
Net Long Term Debt Issuance-0.03 Cr-0.08 Cr-0.10 Cr-0.14 Cr
Long Term Debt Payments-0.03 Cr-0.08 Cr-0.10 Cr-0.14 Cr
Investing Cash Flow-199.51 Cr-17.08 Cr11.13 Cr-144.57 Cr
Net Other Investing Changes-1.63 Cr1000.00
Interest Received Cfi47.36 Cr27.97 Cr23.77 Cr23.45 Cr
Dividends Received Cfi36000.000.11 Cr0.08 Cr0.71 Cr
Net Investment Purchase And Sale-154.30 Cr24.33 Cr95.52 Cr-41.68 Cr
Sale Of Investment381.38 Cr530.79 Cr662.02 Cr984.27 Cr
Purchase Of Investment-535.68 Cr-506.45 Cr-566.50 Cr-1.03K Cr
Net PPE Purchase And Sale-90.94 Cr-69.49 Cr-108.23 Cr-127.04 Cr
Sale Of PPE5.79 Cr23.90 Cr4.86 Cr5.50 Cr
Purchase Of PPE-96.72 Cr-93.39 Cr-113.09 Cr-132.54 Cr
Operating Cash Flow317.57 Cr220.77 Cr154.91 Cr161.65 Cr
Taxes Refund Paid-102.80 Cr-103.92 Cr-77.30 Cr-79.54 Cr
Change In Working Capital87.94 Cr-20.35 Cr-29.91 Cr-21.72 Cr
Change In Other Current Assets15.87 Cr13.89 Cr-17.40 Cr-26.98 Cr
Change In Payable40.36 Cr10.75 Cr49.70 Cr67.62 Cr
Change In Inventory17.01 Cr-57.96 Cr-23.84 Cr-89.78 Cr
Change In Receivables7.82 Cr5.01 Cr-44.79 Cr25.05 Cr
Other Non Cash Items-43.75 Cr-26.34 Cr-19.73 Cr-19.95 Cr
Provisionand Write Offof Assets0.21 Cr0.08 Cr1.42 Cr2.99 Cr
Depreciation And Amortization53.73 Cr39.92 Cr38.94 Cr37.30 Cr
Depreciation53.73 Cr39.92 Cr30.16 Cr29.53 Cr
Gain Loss On Investment Securities-30.39 Cr-60.35 Cr-15.55 Cr-41.15 Cr
Net Foreign Currency Exchange Gain Loss-0.46 Cr-0.02 Cr-0.08 Cr-0.06 Cr
Gain Loss On Sale Of PPE-4.26 Cr-4.48 Cr-0.91 Cr-1.00 Cr
Net Income From Continuing Operations357.22 Cr396.22 Cr257.80 Cr289.39 Cr
Net Other Financing Charges-36.82 Cr-31.88 Cr-0.58 Cr-21.53 Cr
Amortization Cash Flow9.01 Cr8.78 Cr7.77 Cr7.55 Cr
Net Business Purchase And Sale0.00-0.06 Cr
Purchase Of Business0.00-0.06 Cr

All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.